Publication date: 21 June 2022


Discover the projects of Team 4

DARVAC: Inserm impact Santé

DARVAC: Inserm impact Santé

Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC "Development of vaccines offering innovative early protection against non-viral cancers" based on ghost (Dark) proteins. The project is led by Jerome Galon, with Michel...

read more